FDA clears Tandem Diabetes t:slim X2 insulin pump to deliver bolus via smartphone app

TANDEM DIABETES CARE INC

FDA cleared t:slim X2 insulin pump to program and cancel bolus insulin doses using t:connect mobile app on iOS and Android.
First smartphone app to receive FDA clearance for insulin delivery on both operating systems.
Feature will be available via remote software update at no extra cost to new and in-warranty customers.
Rollout begins spring with limited launch groups, expanded launch expected later summer.
CEO John Sheridan highlights this as one of most requested feature enhancements for Control-IQ technology.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.